ImmuCell Corp.
56 Evergreen Drive
Portland,
ME 04103
United States - Map
Phone: 207-878-2770
Fax: 207-878-2117
Web Site: http://www.immucell.com
| ImmuCell Corporation, an animal health biotechnology company, engages in the development, manufacture, and sale of products that improve animal health and productivity in the United States and internationally. It offers First Defense, an orally delivered scours preventive product that is manufactured from cows colostrums using proprietary vaccine and milk protein purification technologies. The company also provides products that aid in the management of inflammation of the mammary gland caused by bacterial infections, including Wipe Out Dairy Wipes, which consist of pre-moistened, biodegradable towelettes that are impregnated with Nisin to prepare the teat area of a cow in advance of milking; MASTiK, a mastitis antibiotic susceptibility test kit; and California Mastitis Test (CMT), which is performed at cow-side for early detection of mastitis. CMT can be used for bulk tank and individual cow sample monitoring, and for determining the quarter of the udder that is mastitic. In addition, it offers Rapid Johnes Test, which identifies cattle with symptomatic Johnes disease in a herd. Additionally, ImmuCell Corporation focuses on developing Mast Out, an intramammary infusion product containing Nisin for use in the treatment of mastitis in lactating dairy cows. It sells and markets its products primarily to veterinarians and producers in the dairy and beef industries. The company was founded in 1982 and is based in Portland, Maine. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Michael F. Brigham , 48
Chief Exec. Officer, Pres, Chief Financial Officer, Sec., Treasurer |
N/A
| N/A | Dr. Joseph H. Crabb Ph.D., 54
Chief Scientific Officer, VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.83% Nasdaq 0.00%
Profile
